Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07599605
PHASE3

Prophylaxis Against Post-Endoscopic Retrograde Cholangio-Pancreatography Pancreatitis.

Sponsor: Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo

View on ClinicalTrials.gov

Summary

Endoscopic retrograde cholangiopancreatography (ERCP) is a key procedure for managing biliopancreatic diseases, although it is associated with complications such as post-ERCP pancreatitis. This study assessed the efficacy of a prophylactic protocol combining rectal indomethacin with aggressive hydration to reduce the incidence of post-ERCP pancreatitis and serum amylase and lipase levels.

Official title: Efficacy of Rectal Indomethacin Plus Aggressive Hydration as Prophylaxis to Prevent Post-ERCP Pancreatitis at a Secondary-Care Teaching Hospital: A Randomized Controlled Trial.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2024-03-04

Completion Date

2025-01-17

Last Updated

2026-05-20

Healthy Volunteers

No

Interventions

DRUG

Rectal Indometacin

The gold standard for treating diseases affecting the biliopancreatic ducts, choledocholithiasis being the most common indication, for which sphincterotomy is the most frequently performed procedure.

Locations (1)

Chihuahua City General Hospital "Dr. Salvador Zubirán Anchondo"

Chihuahua City, Chihuahua, Mexico